武汉云克隆科技股份有限公司

半胱氨酸蛋白酶抑制剂B(CSTB)抗体对

Antibody Pair for Cystatin B (CSTB)

Cys-B; CST6; EPM1; PME; STFB; CPI-B; Stefin B; Liver thiol proteinase inhibitor

  • 半胱氨酸蛋白酶抑制剂B(CSTB)抗体对产品包装(模拟)
  • 半胱氨酸蛋白酶抑制剂B(CSTB)抗体对产品包装(模拟)
  • Certificate通过ISO 9001、ISO 13485质量体系认证

配对实验

用法

储存

避免反复冻融。2-8°C不超过一个月，-80°C不超过12个月。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。

相关产品

编号适用物种：Rattus norvegicus (Rat，大鼠)应用(仅供研究使用，不用于临床诊断！)
RPJ322Ra01半胱氨酸蛋白酶抑制剂B(CSTB)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAJ322Ra01半胱氨酸蛋白酶抑制剂B(CSTB)多克隆抗体WB; IHC; ICC; IP.
LAJ322Ra71半胱氨酸蛋白酶抑制剂B(CSTB)多克隆抗体(生物素标记)WB; IHC; ICC.
MAJ322Ra24半胱氨酸蛋白酶抑制剂B(CSTB)单克隆抗体WB
MAJ322Ra26半胱氨酸蛋白酶抑制剂B(CSTB)单克隆抗体WB
MAJ322Ra22半胱氨酸蛋白酶抑制剂B(CSTB)单克隆抗体WB; IHC; ICC; IP.
MAJ322Ra21半胱氨酸蛋白酶抑制剂B(CSTB)单克隆抗体WB; IHC
LAJ322Ra74半胱氨酸蛋白酶抑制剂B(CSTB)单克隆抗体(生物素标记)WB; IHC; ICC.
SEJ322Ra半胱氨酸蛋白酶抑制剂B(CSTB)检测试剂盒(酶联免疫吸附试验法)Enzyme-linked immunosorbent assay for Antigen Detection.
LMJ322Ra半胱氨酸蛋白酶抑制剂B(CSTB)等多因子检测试剂盒(流式荧光发光法)FLIA Kit for Antigen Detection.
PSJ322Ra01半胱氨酸蛋白酶抑制剂B(CSTB)抗体对ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays.
KSJ322Ra01半胱氨酸蛋白酶抑制剂B(CSTB)检测试剂盒DIY材料(酶联免疫吸附试验法)Main materials for "Do It (ELISA Kit) Yourself".

参考文献

杂志参考文献
AIDS.Cathepsin B and cystatin B in HIV-seropositive women are associated with infection and HIV-1-associated neurocognitive disorders[PubMed: 23291538]
International Journal of Circumpolar HealthEvaluation of serum procathepsin B, cystatin B and cystatin C as possible biomarkers of ovarian cancer[PubMed: PMC3754495]
PLoS One.Dysregulation of Macrophage-Secreted Cathepsin B Contributes to HIV-1-Linked Neuronal Apoptosis[PubMed: PMC3365072]
Journal of Neuroimmune PharmacologyCocaine potentiates cathepsin B secretion and neuronal apoptosis from HIV-infected macrophages[Pubmed:25209871]
European Journal of Cancer SupplementsA91: Endogenous inhibitors of cysteine proteases and preform of cathepsin B in cancer of reproductive system[Science: Article]
Annals of Clinical BiochemistryDiagnostic specificity and sensitivity of PIVKAII, GP3, CSTB, SCCA1 and HGF for the diagnosis of hepatocellular carcinoma in patients with alcoholic liver cirrhosis.[pubmed:28766361]